Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the long-term impact of Pulmonary Embolism (PE) on heart and lung function, quality of life, ability to work, symptoms of breathlessness and functional status of patients one year after their initial diagnosis and treatment for PE
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Exercise Limitation | Exercise limitation will be assessed by VO2 max (% predicted) on cardiopulmonary exercise testing (CPET) | 1 month |
| Exercise Limitation | Exercise limitation will be assessed by VO2 max (% predicted) on cardiopulmonary exercise testing (CPET) | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Quality of Life | Quality of Life will be assessed using the SF-36v2 questionnaire. | Baseline |
| Quality of Life | Quality of Life will be assessed using the SF-36v2 questionnaire. |
Not provided
Inclusion Criteria:
First episode of acute symptomatic PE that was objectively diagnosed* within last 10 days
Treated with anticoagulants
≥ 18 years old
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients seen in the Emergency Department, in-patient wards, out-patient clinics or anticoagulation clinics.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Susan R Kahn, M.D., M.Sc. | Sir Mortimer B. Davis - Jewish General Hospital | Principal Investigator |
| Andrew Hirsch, M.D. | Sir Mortimer B. Davis - Jewish General Hospital | Principal Investigator |
| John Granton, M.D. | University of Toronto | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| QEII Health Sciences Centre | Halifax | Nova Scotia | B3H 2Y9 | Canada | ||
| The Ottawa Hospital |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 27932051 | Derived | Kahn SR, Hirsch AM, Akaberi A, Hernandez P, Anderson DR, Wells PS, Rodger MA, Solymoss S, Kovacs MJ, Rudski L, Shimony A, Dennie C, Rush C, Geerts WH, Aaron SD, Granton JT. Functional and Exercise Limitations After a First Episode of Pulmonary Embolism: Results of the ELOPE Prospective Cohort Study. Chest. 2017 May;151(5):1058-1068. doi: 10.1016/j.chest.2016.11.030. Epub 2016 Dec 6. | |
| 24469387 |
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Nov 9, 2018 | |
| Reset | Mar 6, 2019 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Nov 9, 2018 | Mar 6, 2019 |
| ID | Term |
|---|---|
| D011655 | Pulmonary Embolism |
| D020246 | Venous Thrombosis |
| ID | Term |
|---|---|
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D004617 | Embolism |
| D016769 | Embolism and Thrombosis |
Not provided
Not provided
Not provided
Not provided
Not provided
platelet-poor plasma
| 1 month |
| Quality of Life | Quality of Life will be assessed using the SF-36v2 questionnaire. | 3 months |
| Quality of Life | Quality of Life will be assessed using the SF-36v2 questionnaire. | 6 months |
| Quality of Life | Quality of Life will be assessed using the SF-36v2 questionnaire. | 12 months |
| Respiratory Disease-Specific Measures | Respiratory Disease-Specific measures will be assessed using the Pulmonary Embolism Quality of Life Questionnaire (PEmb-QOL) and the San Diego Shortness of Breath Questionnaire (SOBQ). | Baseline |
| Respiratory Disease-Specific Measures | Respiratory Disease-Specific measures will be assessed using the Pulmonary Embolism Quality of Life Questionnaire (PEmb-QOL) and the San Diego Shortness of Breath Questionnaire (SOBQ). | 1 month |
| Respiratory Disease-Specific Measures | Respiratory Disease-Specific measures will be assessed using the Pulmonary Embolism Quality of Life Questionnaire (PEmb-QOL) and the San Diego Shortness of Breath Questionnaire (SOBQ). | 3 months |
| Respiratory Disease-Specific Measures | Respiratory Disease-Specific measures will be assessed using the Pulmonary Embolism Quality of Life Questionnaire (PEmb-QOL) and the San Diego Shortness of Breath Questionnaire (SOBQ). | 6 months |
| Respiratory Disease-Specific Measures | Respiratory Disease-Specific measures will be assessed using the Pulmonary Embolism Quality of Life Questionnaire (PEmb-QOL) and the San Diego Shortness of Breath Questionnaire (SOBQ). | 12 months |
| Ottawa |
| Ontario |
| K1Y 4E9 |
| Canada |
| Toronto General Hospital | Toronto | Ontario | M5G 2N2 | Canada |
| Sir Mortimer B. Davis - Jewish General Hospital | Montreal | Quebec | H3T 1E2 | Canada |
| St. Mary's Hospital Center | Montreal | Quebec | H3T 1M5 | Canada |
| Derived |
| Kahn SR, Houweling AH, Granton J, Rudski L, Dennie C, Hirsch A. Long-term outcomes after pulmonary embolism: current knowledge and future research. Blood Coagul Fibrinolysis. 2014 Jul;25(5):407-15. doi: 10.1097/MBC.0000000000000070. |
| D014652 |
| Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D013927 | Thrombosis |